Fermenta Biotech [FERMENTA] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Fermenta Biotech Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fermenta Biotech Ltd. wins in 7 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fermenta Biotech Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 10.85 67.11 Fermenta Biotech Ltd.
Price-to-Book Ratio 2.40 10.82 Fermenta Biotech Ltd.
Debt-to-Equity Ratio 29.03 0.58 Divi's Laboratories Ltd.
PEG Ratio -0.17 4.63 Divi's Laboratories Ltd.
EV/EBITDA 8.13 48.63 Fermenta Biotech Ltd.
Profit Margin (TTM) 16.00% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 14.26% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 14.26% 29.65% Divi's Laboratories Ltd.
Return on Equity 21.44% 14.64% Fermenta Biotech Ltd.
Return on Assets (TTM) 12.51% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $187.69M $2.15B Divi's Laboratories Ltd.
Dividend Yield 0.71% 0.91% Divi's Laboratories Ltd.
1-Year Return -5.37% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.71 16.18 Fermenta Biotech Ltd.
Enterprise Value $9.90B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.82 15.86 Fermenta Biotech Ltd.
Gross Profit Margin (TTM) 62.42% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $186 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $29.63 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) -0.13 0.19 Fermenta Biotech Ltd.

Fermenta Biotech Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

FERMENTA
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fermenta Biotech Ltd.0.80%8.12%5.90%0.46%17.65%-9.36%
Divi's Laboratories Ltd.0.30%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fermenta Biotech Ltd.-5.37%110.03%-8.87%55.86%55.86%55.86%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Fermenta Biotech Ltd. vs Divi's Laboratories Ltd.

MetricFERMENTADIVISLAB
Market Information
Market Cap i₹9.28B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i14,040253,443
90 Day Avg. Volume i18,796283,911
Last Close₹319.55₹6,596.50
52 Week Range₹256.40 - ₹399.00₹5,636.50 - ₹7,071.50
% from 52W High-19.91%-6.72%
All-Time High₹449.00 (Feb 10, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-28.83%-6.72%
Growth Metrics
Quarterly Revenue Growth-0.12%0.12%
Quarterly Earnings Growth-0.66%-0.01%
Financial Health
Profit Margin (TTM) i0.16%0.24%
Operating Margin (TTM) i0.14%0.30%
Return on Equity (TTM) i0.21%0.15%
Debt to Equity (MRQ) i29.030.58
Cash & Liquidity
Book Value per Share (MRQ)₹134.13₹580.95
Cash per Share (MRQ)₹17.83₹122.95
Operating Cash Flow (TTM) i₹-59,490,000₹19.67B
Levered Free Cash Flow (TTM) i₹768.62M₹21.91B
Dividends
Last 12-Month Dividend Yield i0.71%0.91%
Last 12-Month Dividend i₹2.50₹60.00

Valuation & Enterprise Metrics Analysis: Fermenta Biotech Ltd. vs Divi's Laboratories Ltd.

MetricFERMENTA (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.8567.11
Forward P/E iN/A53.75
PEG Ratio i-0.174.63
Price to Sales (TTM) i1.7116.18
Price to Book (MRQ) i2.4010.82
Market Capitalization
Market Capitalization i₹9.28B₹1.69T
Enterprise Value i₹9.90B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.8215.86
Enterprise to EBITDA i8.1348.63
Risk & Other Metrics
Beta i-0.130.19
Book Value per Share (MRQ) i₹134.13₹580.95

Financial Statements Comparison: Fermenta Biotech Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFERMENTA (2025)DIVISLAB (2025)
Revenue/Sales i4.67B93.25B
Cost of Goods Sold i1.63B38.70B
COGS % of Revenue i35.0%41.5%
Gross Profit i3.04B54.55B
Gross Margin i65.0%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i933.53M25.71B
Operating Margin i20.0%27.6%
EBITDA i1.24B33.19B
EBITDA Margin i26.6%35.6%
Pre-Tax Income i832.08M29.16B
Pre-Tax Income % of Revenue i17.8%31.3%
Income Tax i68.05M7.25B
Income Tax % of Revenue i1.5%7.8%
Net Income (Profit) i764.03M21.91B
Profit Margin i16.4%23.5%

Balance Sheet & Liquidity Metrics

MetricFERMENTA (2025)DIVISLAB (2025)
Cash & Equivalents i282.40M4.15B
Total Current Assets i3.35B100.81B
Total Current Assets % of Revenue i71.8%108.1%
Total Current Liabilities i2.12B14.52B
Total Current Liabilities % of Revenue i45.4%15.6%
Long-Term Debt i194.91M20.00M
Long-Term Debt % of Revenue i4.2%0.0%
Total Shareholders Equity i3.59B149.69B
Retained Earnings i3.25B134.00B
Retained Earnings % of Revenue i69.7%143.7%
Property, Plant & Equipment i2.16B3.19B

Cash Flow Statement Comparison

MetricFERMENTA (2025)DIVISLAB (2025)
Operating Cash Flow i-59.49M19.67B
Operating Cash Flow % of Revenue i-1.3%21.1%
Capital Expenditures i-28.82M-14.38B
Free Cash Flow i187.69M2.15B
FCF Margin i4.0%2.3%
Debt Repayment i-358.24MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFERMENTADIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i28.87M265.47M
Float Shares i8.42M117.72M
% Held by Insiders i71.66%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i28.34%19.31%

Dividend Analysis & Yield Comparison: Fermenta Biotech Ltd. vs Divi's Laboratories Ltd.

MetricFERMENTADIVISLAB
Last 12-Month Dividend i₹2.50₹60.00
Last 12-Month Dividend Yield i0.71%0.91%
3-Year Avg Annual Dividend i₹0.83₹50.00
3-Year Avg Dividend Yield i0.71%0.70%
3-Year Total Dividends i₹2.50₹150.00
Ex-Dividend DateAug 06, 2025Jul 25, 2025